Company Information

  

Address: 34790 Ardentech Court  
City: Fremont 
State: CA 
Zip Code: 94555 
Telephone: (510) 745-1200 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Zosano Pharma Corporation and its subsidiary ("Company") is a clinical stage pharmaceutical company that has developed a proprietary intracutaneous delivery system. It can offer rapid absorption of drug, consistent drug delivery, improved ease of use and room-temperature stability, benefits that we believe differentiate our delivery platform from other non-oral formulations or injections. By focusing our development efforts on the delivery of established molecules with known safety and efficacy and premium pricing, we plan to reduce our clinical and regulatory risk and development costs and accelerate our time to commercialization. Our intracutaneous patch consists of an array of titanium microneedles that is coated with our proprietary formulation of a previously approved drug that is attached to an adhesive patch.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2017-1.41NAN/E
03/2017-1.83NAN/E
12/2016-2.17NAN/E
09/2015-0.33NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.15Total Liab/Total Assets0.79
Net Inc/Total Assets-1.43Total Liab/Inv Cap3.22
Net Inc/Inv Cap-5.86Total Liab/Comm Equity0.08
Pretax Inc/Net SalesNAInterest Coverage Ratio-24.03
Net Inc/Net SalesNACurr Debt/Equity1.34
Cash Flow/Net SalesNALTD/Equity1.46
SG&A/NetSalesNATotal Debt/Equity2.80
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio1.56
Inventory TurnoverNACurrent Ratio1.56
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 0.00 0.00 0.00 0.00
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 2.19 2.12 2.04 2.01
Operating Income -6.55 -6.75 -7.45 -7.13
Interest Exp 0.21 0.25 0.24 0.31
Pretax Income -6.75 -7.00 -7.75 -7.45
Other Income 0.01 -0.00 -0.06 0.00
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -6.75 -7.00 -7.75 -7.45

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 28.23 37.34 15.00 23.06
Receivables - Total NA NA 0.00 0.03
Inventories - Total NA NA NA NA
Total Current Assets 29.39 38.10 15.28 23.50
Net Property, Plant & Equipment 4.80 4.90 5.46 6.11
Total Assets 34.64 43.18 20.91 30.03
Liabilities        
Accounts Payable 2.93 3.45 3.83 3.94
Debt in Current Liabilities 6.12 6.11 5.99 5.93
Total Current Liabilities 9.04 9.56 9.82 9.87
Long-Term Debt 3.52 5.05 6.55 8.10
Total Liabilities 12.69 14.66 16.42 18.02
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA 0.00 NA
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -210.51 -203.77 -196.77 -188.97
Treasury Stock NA NA NA NA
Total Stockholders' Equity 21.96 28.52 4.49 12.01
Total Liabilities and Stockholders' Equity 34.64 43.18 20.91 30.03

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -7.15 -6.98 -6.88 -5.07
Net Cash Provided by Investing Activities -7.60 -0.08 4.22 8.92
Net Cash Provided by Financing Activities -1.44 29.39 -1.51 5.28

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20134.25-5.61--
12/20142.86-14.24--
12/20150.31-28.43--
12/20160.00-29.83-2.17
Growth Rates-100.00----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17338,88222.64




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.